SHARDACROP · Concall Summary
SHARDA CROPCHEM LTD.
Sharda Cropchem Limited reported its Q1 FY 2026-27 financial results during the earnings call held on July 30, 2026. Management highlighted a 9% year-on-year revenue increase to Rs. 1,074 crores, with gross margins expanding by 120 basis points to 36.7%. EBITDA grew by 25% to Rs. 178 crores, reflecting improved profitability driven by a favorable product mix and growth in NAFTA and LATAM markets. However, Europe experienced a temporary decline in performance due to distributor stock cutbacks amid unusual weather conditions. Management noted that total product registrations increased to 3,016, with 1,027 applications pending approval. The company maintained its FY27 guidance of 10%-15% revenue growth and gross margins between 35%-37%. Management also confirmed a debt-free status with cash and liquid investments of Rs. 767 crores as of June 30, 2026. The call concluded with management expressing confidence in future performance despite current challenges.
Management provided a balanced overview of performance, highlighting both growth and challenges.
View source filing →Earlier concalls
- 2026-07-29 — On July 29, 2026, Sharda Cropchem Limited submitted an investor presentation detailing its unaudited financial results f…
- 2026-05-19 — During the earnings call for Q4 FY 2025-26, management reported that the fiscal year was the best in Sharda Cropchem's h…
- 2026-05-13 — The investor presentation by Sharda Cropchem Limited, dated May 13, 2026, outlines the company's audited financial resul…
See SHARDACROP's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free